Literature DB >> 4452657

Salinomycin, a new polyether antibiotic.

Y Miyazaki, M Shibuya, H Sugawara, O Kawaguchi, C Hirsoe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4452657     DOI： 10.7164/antibiotics.27.814

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  62 in total

1.  Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK.

Authors:  Bei Zhang; Xueya Wang; Fengfeng Cai; Weijie Chen; Uli Loesch; Johannes Bitzer; Xiao Yan Zhong
Journal:  Tumour Biol       Date:  2012-07-07

2.  Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein.

Authors:  Ju-Hwa Kim; Minji Chae; Won Ki Kim; You-Jin Kim; Han Sung Kang; Hyung Sik Kim; Sungpil Yoon
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.

Authors:  Masaya Kai; Noriko Kanaya; Shang V Wu; Carlos Mendez; Duc Nguyen; Thehang Luu; Shiuan Chen
Journal:  Breast Cancer Res Treat       Date:  2015-04-23       Impact factor: 4.872

4.  Apoptotic effects of salinomycin on human ovarian cancer cell line (OVCAR-3).

Authors:  Fuat Kaplan; Fulya Teksen
Journal:  Tumour Biol       Date:  2015-10-18

5.  Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest.

Authors:  Won Ki Kim; Ju-Hwa Kim; Kyungsil Yoon; Sunshin Kim; Jungsil Ro; Han Sung Kang; Sungpil Yoon
Journal:  Invest New Drugs       Date:  2011-05-15       Impact factor: 3.850

6.  Utilization of a lipid substrate for submerged fermentation of Streptomyces albus.

Authors:  P Procházka; M Nohýnek; Z Vanĕk; J Rokos
Journal:  Folia Microbiol (Praha)       Date:  1983       Impact factor: 2.099

Review 7.  Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Emmanouil Kalampokas; Theodoros Kalampokas; Eleftherios Spartalis; Afrodite Daskalopoulou; Serena Valsami; Michael Kontos; Afroditi Nonni; Konstantinos Kontzoglou; Despina Perrea; Nikolaos Nikiteas; Dimitrios Dimitroulis
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

8.  Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk.

Authors:  Chao Liu; Ligang Wang; Hongmei Qiu; Qing Dong; Yong Feng; Dawei Li; Chengli Li; Cundong Fan
Journal:  Neurochem Res       Date:  2018-05-26       Impact factor: 3.996

9.  Discovery of a (19)F MRI sensitive salinomycin derivative with high cytotoxicity towards cancer cells.

Authors:  Qiuyan Shi; Yu Li; Shaowei Bo; Xiaofei Li; Peng Zhao; Qi Liu; Zhigang Yang; Hengjiang Cong; Hexiang Deng; Mingnan Chen; Shizhen Chen; Xin Zhou; Hong Ding; Zhong-Xing Jiang
Journal:  Chem Commun (Camb)       Date:  2016-03-21       Impact factor: 6.222

10.  The action of polyether ionophorous antibiotics (monensin, salinomycin, lasalocid) on developmental stages of Eimeria tenella (Coccidia, Sporozoa) in vivo and in vitro: study by light and electron microscopy.

Authors:  H Mehlhorn; H Pooch; W Raether
Journal:  Z Parasitenkd       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.